T. Rowe Price Associates’s Predictive Oncology POAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,395
| Closed | -$70K | – | 2944 |
|
|
2022
Q4 | $70K | Hold |
11,395
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q3 | $83K | Hold |
11,395
| – | – | ﹤0.01% | 2762 |
|
|
2022
Q2 | $93K | Hold |
11,395
| – | – | ﹤0.01% | 2760 |
|
|
2022
Q1 | $223K | Hold |
11,395
| – | – | ﹤0.01% | 2667 |
|
|
2021
Q4 | $217K | Buy |
11,395
+3,020
| +36% | +$57.5K | ﹤0.01% | 2723 |
|
|
2021
Q3 | $223K | Buy |
8,375
+3,065
| +58% | +$81.6K | ﹤0.01% | 2678 |
|
|
2021
Q2 | $139K | Buy |
+5,310
| New | +$139K | ﹤0.01% | 2786 |
|